| Detected | Trial | Change |
|---|---|---|
| 2026-05-21 | NCT06742190 A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-21 | NCT06742190 A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With… |
Primary endpoint(s) modified |
| 2026-05-21 | NCT06742190 A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With… |
Enrollment increased: 115 -> 154 participants |
| 2026-05-19 | NCT06290141 A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of… |
Trial sites expanded: 118 -> 122 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT04474223 | Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur… | AVB - Atrioventricular Block | Recruiting |
| NCT06920004 | A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP | Chronic Inflammatory Demyelinating Polyneuropathy | Recruiting |
| NCT06290141 | A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of… | Chronic Inflammatory Demyelinating Polyneuropathy | Recruiting |
| NCT06742190 | A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With… | Multifocal Motor Neuropathy (MMN) | Active, Not Recruiting |
| Phase 2 | |||
| NCT06305793 | RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG) | Long COVID | Active, Not Recruiting |